TL;DR
Researchers have successfully created an ASPM knockout cynomolgus monkey, revealing that ASPM is crucial for primate brain development, particularly for oligodendrocyte survival. This model exhibits severe microcephaly and a significant loss of oligodendrocytes, offering a more relevant platform than rodents for studying human microcephaly and related neurodevelopmental disorders.
What Problem Does This Paper Address?
Microcephaly, a condition characterized by a smaller than normal head circumference, is a significant developmental disorder with various genetic causes. The abnormal spindle-like microcephaly-associated (ASPM) gene is a major culprit, implicated in a common form of primary hereditary microcephaly. While ASPM's role in brain development, especially in progenitor cells during neurogenesis, is known, its precise function and the consequences of its mutation in non-human primates—animals with gyrated brains similar to humans—remained largely unexplored. Rodent models, lacking significant cortical folding, are limited in their ability to fully recapitulate primate brain development. Therefore, there's a critical need for a primate model to understand ASPM's function in a more evolutionarily relevant context.
Methods
The researchers employed CRISPR/Cas9 gene editing technology to create an ASPM knockout (KO) in cynomolgus monkeys. They targeted key exons (exon 3 and exon 9) of the monkey ASPM gene by injecting gRNAs and Cas9 mRNA into fertilized eggs. These embryos were then transferred to surrogate mothers, leading to the birth of several live monkeys. Genetic validation of the knockout was performed using T7E1 and BsmAI digest assays, followed by DNA sequencing to confirm frameshift mutations and deletions. Phenotypic analysis involved macroscopic examination of brain size, body weight, and head circumference. Histological analysis included immunocytochemistry for neuronal markers (NeuN) and oligodendrocyte markers (Olig2), as well as Western blot analysis for neuronal maturation markers (DCX) and myelin-related proteins (MBP, Olig2, MOG), and synaptic proteins (PSD95, synaptophysin, SNAP25, MAP2).
Datasets
Not discussed in the paper. The study primarily relies on the generation and analysis of a novel ASPM knockout primate model.
Key Insights and Ideas
- Primate-specific ASPM function: The study highlights that ASPM plays a critical and specific role in primate brain development, particularly in the survival and function of oligodendrocytes, a cell type crucial for brain expansion and gyrification.
- Oligodendrocyte vulnerability: The severe microcephaly observed in the ASPM KO monkey is directly linked to a striking deficit in oligodendrocytes, a phenotype not previously reported in other ASPM KO models. This suggests a unique vulnerability of these cells to ASPM deficiency in primates.
- Model system relevance: The cynomolgus monkey model, with its gyrated cerebral cortex, provides a more accurate platform for studying ASPM function and microcephaly than rodent models, which lack this key feature of primate brain development.
- Multi-exon targeting for severe phenotype: Targeting multiple exons (3 and 9) of the ASPM gene appears to be crucial for achieving a complete loss of function and a severe phenotype, likely eliminating all protein isoforms and leading to the observed oligodendrocyte loss.
Key Results
- One out of six live-born cynomolgus monkeys exhibited a complete knockout of the ASPM gene.
- The ASPM KO monkey displayed severe microcephaly, with its whole brain weight being only 28.4% of the control at 9 months of age.
- Histological analysis revealed a significant reduction in oligodendrocyte density in the ASPM KO monkey's prefrontal cortex.
- Western blot analysis showed decreased levels of myelin-related proteins (MBP, Olig2, MOG) and synaptic proteins (PSD95, synaptophysin, SNAP25, MAP2) in the ASPM KO monkey, consistent with oligodendrocyte dysfunction.
- The ASPM KO monkey also showed increased density of NeuN-positive cells and elevated levels of DCX, indicating impaired neuronal maturation.
Limitations and Future Work
The authors acknowledge a significant limitation: only one ASPM KO monkey was successfully generated, which limits the statistical power and generalizability of the findings. The rarity of biallelic knockout animals in non-human primates is a known challenge. Furthermore, the ASPM KO monkey died at 9 months of age from pneumonia, preventing long-term observation of developmental trajectories and compensatory mechanisms.
Future research should focus on exploring the molecular pathways through which ASPM regulates oligodendrocyte development. The authors also suggest investigating potential therapeutic strategies to mitigate the effects of ASPM deficiency. The development of more efficient gene editing techniques in non-human primates would also be beneficial for future studies.
Summary updated